about
The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspectsClinical correlates of grey matter pathology in multiple sclerosisEpigenetic Drugs for Multiple Sclerosis(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areasPathology of multiple sclerosis: where do we stand?Grey matter lesions in MS: from histology to clinical implications.Bringing CLARITY to gray matter atrophy.Gray matters in multiple sclerosis: cognitive impairment and structural MRI.Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis.Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy.The neurocognitive profile of the cerebellum in multiple sclerosisMRI in multiple sclerosis: what's inside the toolbox?Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosisMRI in multiple sclerosis: current status and future prospectsQuantitative electroencephalography reveals different physiological profiles between benign and remitting-relapsing multiple sclerosis patientsHistological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination modelSample size requirements for treatment effects using gray matter, white matter and whole brain volume in relapsing-remitting multiple sclerosisIdentification and clinical impact of multiple sclerosis cortical lesions as assessed by routine 3T MR imaging.Cortical pathology and cognitive impairment in multiple sclerosis.Progressive multiple sclerosis and gray matter pathology: an MRI perspective.Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosisCerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes.Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.Cortical injury in multiple sclerosis; the role of the immune system.Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.Meningeal and cortical grey matter pathology in multiple sclerosis.The neuropathological basis of clinical progression in multiple sclerosis.The NEO-FFI in Multiple Sclerosis: internal consistency, factorial validity, and correspondence between self and informant reports.Periventricular demyelination and axonal pathology is associated with subependymal virus spread in a murine model for multiple sclerosis.Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patientsExtensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space.Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration.Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.Gray matter atrophy in multiple sclerosis: a longitudinal study.Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
P2860
Q26851476-40B946D7-B762-4169-AF00-6780AB98F219Q26999302-D6108532-7AD9-42AD-8195-66B84073272EQ28076395-FB9B6024-F201-4658-BD72-3298A4273E29Q28259782-4FF9B5F6-782D-41A9-9A46-BEF881B11DABQ28296052-0DF14E99-638A-42D4-833E-27226D7C9626Q30574566-B6F134A4-093B-4A22-A536-EEDF2B5623B4Q30651109-8AFEAAF8-471D-424A-AE74-3FFFAA8CD401Q30768942-06658168-128C-45EA-BDFC-61C5BE3F3BA2Q30850163-49EF79A3-16AE-4052-ABD4-0CAAA9220F40Q30869048-28409EF0-99EB-4BF9-801F-A1412D17B350Q30962250-D52AEC07-1F39-4FF6-B04B-8F12432C9653Q31132442-A27F2545-0B2E-4A69-8D81-30CBE189B3ABQ33339985-D12A8515-C569-429F-8F25-295D07D1AC25Q33345057-264B2C75-7DB4-47CC-8F35-8D1A97417AB0Q33386254-D7D16D23-646E-4280-BCB0-AB35069B5CE0Q33594716-C040CCD3-EB83-4081-B906-74812EAA297AQ33757630-59EABB2A-7139-4BE1-9482-13AC992FE97AQ33817835-6BC9C0BA-FEF5-4026-99AC-EAFF3A7C2D5FQ33837296-3C8FF5E5-C30D-4B7B-8D19-78752F5D6FF6Q33852170-D106D428-9AB2-46A5-B174-76755BC7E690Q33928228-D1F4D0CA-9A3C-411C-A206-65BF7AD897B2Q33946311-74155A0C-070A-48D3-9FB6-06FA09B9DD2AQ34076168-99678C1B-7420-4759-AD84-5ECA0B6E895EQ34092684-A787D425-1569-4745-A078-6992C739A13BQ34118301-E7469949-DB38-4D7D-AA2D-5E86F67E10ACQ34187428-546DDCCC-5C5D-41E8-AD2B-DABBAD66CCB1Q34188436-F9B05972-AC89-4B27-915F-5E1FF6C69945Q34192249-85363B70-910D-444D-B002-FF94F83D369FQ34248843-5E9283A8-0457-479E-AA7D-8AFC406F6B8EQ34295012-20EE36D0-4F91-45CB-8369-4DA5C6487912Q34402792-A0BB2E4F-313C-471E-A18A-7B1A5B26DF64Q34449329-AC774908-EEEE-446F-B9CD-0C4D3F630451Q34474046-180CA898-1D34-4DAE-A6CB-07BC1001F306Q34582216-0134DC6A-3117-4D22-BC9C-ABEBE416C135Q34594049-6C197F4C-714F-4901-B45A-168F3F4377E9Q34646572-D2B0B266-98B2-42E7-8E35-437B4EF54E0AQ34733726-9851E7DA-93A4-4FF2-AC84-F03F887BDCC1Q34801849-75FAD416-3E53-47E0-A5C1-34AF139BD59AQ34988315-C2AA15AD-A535-40D5-ACE9-42D7EF8CC930Q35224690-AE7048C8-3830-4767-9C58-68D835A2EA2F
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Gray matter involvement in multiple sclerosis
@ast
Gray matter involvement in multiple sclerosis
@en
Gray matter involvement in multiple sclerosis
@nl
type
label
Gray matter involvement in multiple sclerosis
@ast
Gray matter involvement in multiple sclerosis
@en
Gray matter involvement in multiple sclerosis
@nl
prefLabel
Gray matter involvement in multiple sclerosis
@ast
Gray matter involvement in multiple sclerosis
@en
Gray matter involvement in multiple sclerosis
@nl
P2093
P3181
P1433
P1476
Gray matter involvement in multiple sclerosis
@en
P2093
Claudia F Lucchinetti
Istvan Pirko
Rohit Bakshi
Subramaniam Sriram
P304
P3181
P356
10.1212/01.WNL.0000250267.85698.7A
P407
P577
2007-02-27T00:00:00Z